A groundbreaking #cancervaccine is in the midst of clinical trials at basserbrca. The shot would benefit those carrying cancer-causing #BRCA gene mutations by recognizing the earliest signs of disease and stopping cancer before it develops. “If there’s a word beyond ‘breakthrough’, that’s what [this] would be,” says Robert Vonderheide, MD, DPhil, director of the Abramson Cancer Center. Learn more from principal investigator and basserbrca executive director Susan Domchek, MD, at the link in our bio.